Transplantation of the intestine: Is it truly different?

American Journal of Transplantation

Volumn 3, Issue 1, 2003, Pages 1-2

  Newell, Kenneth A ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLOGRAFT; ANTIBODY SPECIFICITY; BIOPSY TECHNIQUE; EDEMA; EVALUATION; EXTRAVASATION; GRAFT REJECTION; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INTESTINE TRANSPLANTATION; OUTCOMES RESEARCH; REVIEW; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

GRAFT REJECTION; HUMANS; INTESTINES; ORGAN SPECIFICITY;

EID: 0037219135     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.30101.x     Document Type: Review

References (10)

1. Zhang Z, Zhu L, Quan D et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996; 62: 1267-1272.
2. Hara M, Kingsley CI, Smith CH et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001; 166 (4): 2824-2830.
3. Grant D. Intestinal transplantation: 1997 report of the international registry: Intestinal Transplant Registry. Transplantation 1999; 67 (7): 1061-1064.
4. Fox IJ, McCashland TM, Schafer DF et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000; 95 (6): 1506-1515.
5. Nery JR, Mittal N, Hadjis N et al. Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg 2002; 6 (2): 233-239.
6. Krieger NR, Yin DP, Garrison Fathman C. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184 (5): 2013-2018.
7. Kim O, Szot GL, Rulifson I et al. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 1999; 163 (5): 2358-2362.
8. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57 (12): 1701-1706.
9. Brady W, Leiden JM, Wei RQ et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992; 89 (22): 11102-11105.
10. Halloran PF. Call for revolution: a new approach to describing allograft deterioration. Am J Transplant 2002; 2 (3): 195-200.